Kyoichi Wada

430 total citations
36 papers, 264 citations indexed

About

Kyoichi Wada is a scholar working on Surgery, Transplantation and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kyoichi Wada has authored 36 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 13 papers in Transplantation and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kyoichi Wada's work include Renal Transplantation Outcomes and Treatments (12 papers), Transplantation: Methods and Outcomes (12 papers) and Mechanical Circulatory Support Devices (9 papers). Kyoichi Wada is often cited by papers focused on Renal Transplantation Outcomes and Treatments (12 papers), Transplantation: Methods and Outcomes (12 papers) and Mechanical Circulatory Support Devices (9 papers). Kyoichi Wada collaborates with scholars based in Japan and Somalia. Kyoichi Wada's co-authors include Mitsutaka Takada, Takeshi Nakatani, Kouichi Hosomi, Akiko Mano, Mai Fujimoto, Akihisa Hanatani, Takeshi Kuwahara, Tomohiro Hayashi, Soichiro Kitamura and Koji Y. Arai and has published in prestigious journals such as International Journal of Cardiology, European Journal of Clinical Pharmacology and The Journal of Heart and Lung Transplantation.

In The Last Decade

Kyoichi Wada

35 papers receiving 257 citations

Peers

Kyoichi Wada
Zheng Wu China
Marion Black Australia
Girish Mour United States
Belinda T. Lee United States
G. Javorsky Australia
Gurukripa N. Kowlgi United States
Zheng Wu China
Kyoichi Wada
Citations per year, relative to Kyoichi Wada Kyoichi Wada (= 1×) peers Zheng Wu

Countries citing papers authored by Kyoichi Wada

Since Specialization
Citations

This map shows the geographic impact of Kyoichi Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyoichi Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyoichi Wada more than expected).

Fields of papers citing papers by Kyoichi Wada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyoichi Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyoichi Wada. The network helps show where Kyoichi Wada may publish in the future.

Co-authorship network of co-authors of Kyoichi Wada

This figure shows the co-authorship network connecting the top 25 collaborators of Kyoichi Wada. A scholar is included among the top collaborators of Kyoichi Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyoichi Wada. Kyoichi Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wada, Kyoichi, et al.. (2019). Drug interactions between tacrolimus and clotrimazole troche: a data mining approach followed by a pharmacokinetic study. European Journal of Clinical Pharmacology. 76(1). 117–125. 4 indexed citations
2.
Wada, Kyoichi, et al.. (2018). Effects of clotrimazole on tacrolimus pharmacokinetics in patients with heart transplants with different CYP3A5 genotypes. European Journal of Clinical Pharmacology. 75(1). 67–75. 10 indexed citations
3.
Wada, Kyoichi, et al.. (2018). Effects of vitamin K epoxide reductase complex 1 gene polymorphisms on warfarin control in Japanese patients with left ventricular assist devices (LVAD). European Journal of Clinical Pharmacology. 74(7). 885–894. 2 indexed citations
4.
Wada, Kyoichi, et al.. (2018). Impact of the CYP3A5*1 Allele on the Pharmacokinetics of Tacrolimus in Japanese Heart Transplant Patients. European Journal of Drug Metabolism and Pharmacokinetics. 43(6). 665–673. 7 indexed citations
5.
Kimura, Yuki, Masanobu Yanase, Keiichiro Iwasaki, et al.. (2018). De novo malignancy in heart transplant recipients: A single center experience in Japan. Journal of Cardiology. 73(3). 255–261. 4 indexed citations
6.
Seguchi, Osamu, Yorihiko Matsumoto, Seiko Nakajima, et al.. (2017). Clinical Implication of Non-Complement-Binding Donor-Specific Anti-HLA Antibodies in Heart Transplant Recipients -Risk Stratification by C1q-Binding Capacity. 2(1). 1 indexed citations
7.
Wada, Kyoichi, Koji Miyamoto, Mai Fujimoto, et al.. (2017). The influence of residual apixaban on bleeding complications during and after catheter ablation of atrial fibrillation. Journal of Arrhythmia. 33(5). 434–439. 1 indexed citations
8.
Wada, Kyoichi, et al.. (2017). Association between N-desethylamiodarone/amiodarone ratio and amiodarone-induced thyroid dysfunction. European Journal of Clinical Pharmacology. 73(3). 289–296. 8 indexed citations
9.
Tsubota, Maho, et al.. (2017). Tacrolimus Triggers Transient Receptor Potential Vanilloid-1-Dependent Relapse of Pancreatitis-Related Pain in Mice. Pharmacology. 99(5-6). 281–285. 5 indexed citations
10.
Wada, Kyoichi, Takeshi Kuwahara, Atsufumi Kawabata, et al.. (2016). Circadian pharmacokinetics and limited sampling strategy of everolimus in heart transplant patients. International Journal of Clinical Pharmacology and Therapeutics. 55(1). 1–8. 1 indexed citations
11.
Seguchi, Osamu, Tomoyuki Fujita, Yoshihiro Murata, et al.. (2015). Incidence, etiology, and outcome of primary graft dysfunction in adult heart transplant recipients: a single-center experience in Japan. Heart and Vessels. 31(4). 555–562. 11 indexed citations
12.
Watanabe, Takuya, Osamu Seguchi, Kunihiro Nishimura, et al.. (2015). Suppressive effects of conversion from mycophenolate mofetil to everolimus for the development of cardiac allograft vasculopathy in maintenance of heart transplant recipients. International Journal of Cardiology. 203. 307–314. 11 indexed citations
13.
Yamashita, Daisuke, Kyoichi Wada, Hiroshi Okada, et al.. (2010). Drug Interaction between Voriconazole and Rifampicin after Discontinuation of Rifampicin: A Case Report. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 36(5). 323–327. 1 indexed citations
14.
Sasaoka, Taro, Tomoko S. Kato, Kazuo Komamura, et al.. (2010). Improved long-term performance of pulsatile extracorporeal left ventricular assist device. Journal of Cardiology. 56(2). 220–228. 17 indexed citations
15.
Mano, Akiko, Kyoichi Wada, Koji Y. Arai, et al.. (2009). Body Mass Index is a Useful Predictor of Prognosis After Left Ventricular Assist System Implantation. The Journal of Heart and Lung Transplantation. 28(5). 428–433. 43 indexed citations
16.
Wada, Kyoichi, Mitsutaka Takada, Hiroyuki Ochi, et al.. (2009). Drug Interaction Between Tacrolimus and Carbamazepine in a Japanese Heart Transplant Recipient: A Case Report. The Journal of Heart and Lung Transplantation. 28(4). 409–411. 6 indexed citations
17.
Higashi, Haruhiko, Kazuo Komamura, Noboru Oda, et al.. (2008). Experience of appendicular thermal therapy applied to a patient with a left ventricular assist device awaiting heart transplantation. Journal of Cardiology. 53(2). 301–305. 6 indexed citations
18.
Wada, Kyoichi, Mitsutaka Takada, Takeshi Kotake, et al.. (2007). Limited Sampling Strategy for Mycophenolic Acid in Japanese Heart Transplant Recipients. Circulation Journal. 71(7). 1022–1028. 18 indexed citations
19.
Wada, Kyoichi, et al.. (2004). Promoting Proper use of Ticlopidine Hydrochloride through Prescription Order Entry System. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 30(3). 211–216. 1 indexed citations
20.
Wada, Kyoichi, et al.. (2002). Interaction of Warfarin and Rifampicin on Medical Report.. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 28(1). 85–90. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026